Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
- Cabrera-Serrano, Antonio José 78
- Sánchez-Maldonado, José Manuel 78
- ter Horst, Rob 16
- Macauda, Angelica 2
- García-Martín, Paloma 1
- Benavente, Yolanda 31718
- Landi, Stefano 9
- Clay-Gilmour, Alyssa 24
- Niazi, Yasmeen 2627
- Espinet, Blanca 56
- Rodríguez-Sevilla, Juan José 13
- Pérez, Eva María 1
- Maffei, Rossana 14
- Blanco, Gonzalo 56
- Giaccherini, Matteo 9
- Cerhan, James R. 15
- Marasca, Roberto 14
- López-Nevot, Miguel Ángel 12
- Chen-Liang, Tzu 25
- Thomsen, Hauke 33
- Gámez, Irene 25
- Campa, Daniele 9
- Moreno, Víctor 173132
- de Sanjosé, Silvia 317
- Marcos-Gragera, Rafael 3353637
- García-Álvarez, María 11
- Dierssen-Sotos, Trinidad 34
- Jerez, Andrés 10
- Butrym, Aleksandra 38
- Norman, Aaron D. 15
- Luppi, Mario 14
- Slager, Susan L. 2829
- Hemminki, Kari 1920
- Li, Yang 2223
- Berndt, Sonja I. 21
- Casabonne, Delphine 317
- Alcoceba, Miguel 11
- Puiggros, Anna 56
- Netea, Mihai G. 2234
- Försti, Asta 2627
- Canzian, Federico 2
- Sainz, Juan 37830
- Show all authors +
- 1 Hospital Campus de la Salud, PTS, 18016 Granada, Spain
- 2 Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
- 3 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, 08908 Barcelona, Spain
- 4 Faculty of Medicine, University of Cantabria, 39011 Santander, Spain
- 5 Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain
- 6 Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain
- 7 Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain
- 8 Instituto de Investigación Biosanitaria IBs.Granada, 18012 Granada, Spain
- 9 Department of Biology, University of Pisa, 56126 Pisa, Italy
- 10 Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, 08035 Barcelona, Spain
- 11 Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain
- 12 Immunology Department, Virgen de las Nieves University Hospital, 18014 Granada, Spain
- 13 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 14 Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, 41124 Modena, Italy
- 15 Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
- 16 CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria
- 17 Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain
- 18 CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
- 19 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
- 20 Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic
- 21 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA
- 22 Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- 23 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, Joint Ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), 30625 Hannover, Germany
- 24 Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA
- 25 Hematology Department, Morales Meseguer University Hospital, 30008 Murcia, Spain
- 26 Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
- 27 Hopp Children’s Cancer Center (KiTZ), 69120 Heidelberg, Germany
- 28 Division of Computational Genomics, Mayo Clinic, Rochester, MN 85054, USA
- 29 Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
- 30 Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada (UGR), 18012 Granada, Spain
- 31 Cancer Prevention and Control Program, Unit of Biomarkers and Susceptibility, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, 08907 Barcelona, Spain
- 32 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain
- 33 MSB Medical School Berlin, D-14197 Berlin, Germany
- 34 Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany
- 35 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain
- 36 Department of Nursing, Universitat de Girona, 17007 Girona, Spain
- 37 Josep Carreras Leukemia Research Institute, 08916 Girona, Spain
- 38 Department of Cancer Prevention and Therapy, Medical University of Wrocław, 50-556 Wrocław, Poland
ISSN: 1422-0067
Year of publication: 2023
Volume: 24
Issue: 9
Pages: 8005
Type: Article
More publications in: International Journal of Molecular Sciences
Funding information
Funders
-
European Union’s Horizon 2020 research and innovation program
- 856620
-
Instituto de Salud Carlos III and FEDER
- PI17/02256
- PI20/01845
-
Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER
- PY20/01282
-
US National Cancer Institute
- P50 CA97274
- R01 CA92153
Bibliographic References
- Alaggio, (2022), Leukemia, 36, pp. 1720, 10.1038/s41375-022-01620-2
- Yao, (2022), Biomed. Eng. Online, 21, pp. 4, 10.1186/s12938-021-00973-6
- Parikh, (2014), Haematologica, 99, pp. 140, 10.3324/haematol.2013.086066
- Alrawashdh, (2021), Ann. Hematol., 100, pp. 2501, 10.1007/s00277-021-04600-1
- Hallek, (2021), Am. J. Hematol., 96, pp. 1679, 10.1002/ajh.26367
- Rossi, (2013), Blood, 121, pp. 1403, 10.1182/blood-2012-09-458265
- Berndt, (2016), Nat. Commun., 7, pp. 10933, 10.1038/ncomms10933
- Law, (2017), Nat. Commun., 8, pp. 14175, 10.1038/ncomms14175
- Slager, (2011), Blood, 117, pp. 1911, 10.1182/blood-2010-09-308205
- Broderick, (2008), Nat. Genet., 40, pp. 1204, 10.1038/ng.219
- Call, (1994), Mayo Clin. Proc., 69, pp. 323, 10.1016/S0025-6196(12)62215-0
- Lin, (2021), Nat. Commun., 12, pp. 665, 10.1038/s41467-020-20822-9
- Macauda, (2022), Cancer Epidemiol. Biomark. Prev., 31, pp. 1863, 10.1158/1055-9965.EPI-22-0043
- Diez, (2022), Blood Cancer J., 12, pp. 79, 10.1038/s41408-022-00676-8
- Wu, (2018), Biol. Res., 51, pp. 39, 10.1186/s40659-018-0189-0
- Canzian, (2022), Eur. J. Hum. Genet., 30, pp. 474, 10.1038/s41431-021-00986-8
- Li, (2016), Cell, 167, pp. 1099, 10.1016/j.cell.2016.10.017
- Orru, (2013), Cell, 155, pp. 242, 10.1016/j.cell.2013.08.041